These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12555643)

  • 21. [Feasibility of stroke thrombolysis at Pau Hospital, France].
    Barroso B; Larrieu JM; Morisset C; Carlier P; Bersani D; Dakar A; Lagabrielle JF; Larribau E; Lippa A; Mangon H; Montaut N; Rouanet F
    Presse Med; 2007 Jun; 36(6 Pt 1):859-66. PubMed ID: 17303371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population.
    Delgado MG; Michel P; Naves M; Maeder P; Reichhart M; Wintermark M; Bogousslavsky J
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):282-5. PubMed ID: 19850577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator.
    Poncyljusz W; Falkowski A; Kojder I; Cebula E; Sagan L; Czechowski J; Walecka A
    Acta Radiol; 2007 Sep; 48(7):774-80. PubMed ID: 17729010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience.
    Breuer L; Schellinger PD; Huttner HB; Halwachs R; Engelhorn T; Doerfler A; Köhrmann M
    Int J Stroke; 2010 Apr; 5(2):68-73. PubMed ID: 20446939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis.
    Liu D; Scalzo F; Starkman S; Rao NM; Hinman JD; Kim D; Ali LK; Saver JL; Noorian AR; Ng K; Liang C; Sheth SA; Yoo B; Liu X; Liebeskind DS;
    Cerebrovasc Dis; 2015; 40(5-6):279-285. PubMed ID: 26513397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
    Ciccone A; Valvassori L; Nichelatti M;
    Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
    Kappelle LJ; van der Worp HB
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
    Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N
    Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
    Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register.
    Lees KR; Ford GA; Muir KW; Ahmed N; Dyker AG; Atula S; Kalra L; Warburton EA; Baron JC; Jenkinson DF; Wahlgren NG; Walters MR;
    QJM; 2008 Nov; 101(11):863-9. PubMed ID: 18694900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.